StockData
SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31

Savara Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$4.63+0.18 (+4.04%)

Close on Oct 19, 2026

Market cap
$1.17B
P/E (TTM)
–
Dividend yield
–

Savara Inc balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-63.5%

Financial strength

Current ratio
10.13
Debt to equity
0.21
Debt to assets
15.7%
Cash to current liabilities
237.5%

Valuation

P/E ratio
–
Price to sales
–
Price to book
8.17
Dividend yield
–